Cargando…

Molecular point-of-care testing for influenza A/B and respiratory syncytial virus: comparison of workflow parameters for the ID Now and cobas Liat systems

AIMS: Point-of-care (POC) tests for influenza and respiratory syncytial virus (RSV) offer the potential to improve patient management and antimicrobial stewardship. Studies have focused on performance; however, no workflow assessments have been published comparing POC molecular tests. This study com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Young, Stephen, Phillips, Jamie, Griego-Fullbright, Christen, Wagner, Aaron, Jim, Patricia, Chaudhuri, Sheena, Tang, Shaowu, Sickler, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279563/ https://www.ncbi.nlm.nih.gov/pubmed/31826935 http://dx.doi.org/10.1136/jclinpath-2019-206242

Ejemplares similares

Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection
por: Granato, Paul A., et al.
Publicado: (2018)

Equivalent Performance of the Cobas(®) Cdiff Test for Use on the Cobas(®) Liat(®) System and the Cobas(®) 4800 System
por: Garg, Sachin K, et al.
Publicado: (2017)

Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study
por: Hansen, Glen, et al.
Publicado: (2021)

Comparing the cobas Influenza A/B Nucleic acid test for use on the cobas Liat System (Liat) with rapid antigen tests for clinical management of Japanese patients at the point of care
por: Mikamo, Hiroshige, et al.
Publicado: (2022)

Clinical performance of SARS-CoV-2 detection on the cobas Liat using water gargle samples()
por: Veillette, Maxime, et al.
Publicado: (2022)

2179. Detection of Group A Streptococcus in the Saliva of Children Presenting With Pharyngitis Using the cobas®LIAT® PCR System
por: DeMuri, Gregory P, et al.
Publicado: (2019)

Clinical Performance of the cobas Liat SARS-CoV-2 & Influenza A/B Assay in Nasal Samples
por: Akashi, Yusaku, et al.
Publicado: (2022)

SARS-CoV-2 Testing of Emergency Department Patients Using cobas(®) Liat(®) and eazyplex(®) Rapid Molecular Assays
por: Egerer, Renate, et al.
Publicado: (2023)

Discordant SARS-CoV-2 RNA results obtained using the Roche cobas Liat SARS-CoV-2
por: Warnock, Gayle, et al.
Publicado: (2022)

Implementation of the cobas Liat influenza point-of-care test into an emergency department during a high-incidence season: a retrospective evaluation following real-world implementation
por: Youngs, J., et al.
Publicado: (2019)

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020)

Evaluation of the cobas Liat detection test for SARS-CoV-2 and influenza viruses following the emergence of the SARS-CoV-2 Omicron variant
por: Park, Kuenyoul, et al.
Publicado: (2023)

Evaluation of the Liat Cdiff Assay for Direct Detection of Clostridioides difficile Toxin Genes within 20 Minutes
por: Hetem, David J., et al.
Publicado: (2019)

Performance Characteristics of the Roche Diagnostics cobas Liat PCR System as a COVID-19 Screening Tool for Hospital Admissions in a Regional Health Care Delivery System
por: Blackall, Douglas, et al.
Publicado: (2021)

Comparison of the ID Now Influenza A & B 2, Cobas Influenza A/B, and Xpert Xpress Flu Point-of-Care Nucleic Acid Amplification Tests for Influenza A/B Virus Detection in Children
por: Kanwar, Neena, et al.
Publicado: (2020)

High-Risk Human Papillomavirus Detection via Cobas(®) 4800 and REBA HPV-ID(®) Assays
por: Liewchalermwong, Sasiprapa, et al.
Publicado: (2022)

Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department
por: NguyenVan, Jean-Claude, et al.
Publicado: (2021)

Provider attitudes and satisfaction with rapid preoperative point-of-care COVID-19 testing using ID NOW™
por: Lee, Susan M., et al.
Publicado: (2021)

Evaluation of the COVID19 ID NOW EUA assay
por: Mitchell, Stephanie L., et al.
Publicado: (2020)

Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022)

Evaluation of Abbott ID NOW COVID-19 POC test performance characteristics and integration in the regional health network workflows to improve health care delivery
por: Babic, N., et al.
Publicado: (2023)

Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test
por: Young, Stephen, et al.
Publicado: (2020)

Enabling Smart Workflows over Heterogeneous ID-Sensing Technologies
por: Giner, Pau, et al.
Publicado: (2012)

Cobá : estrategias adaptativas de tres familias mayas /
por: Daltabuit Godas, Magalí
Publicado: (1988)

Comparison of an ID NOW COVID-19 Assay Used at the Point of Care to Laboratory-Based Nucleic Acid Amplification Tests
por: Payne, David, et al.
Publicado: (2023)

The Impact of Point-of-Care Polymerase Chain Reaction Testing on Prescribing Practices in Primary Care for Management of Strep A: A Retrospective Before–After Study
por: May, Larissa, et al.
Publicado: (2022)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

System performance evaluation of the cobas t 711 and cobas t 511 coagulation analyzers in routine laboratory settings
por: Kitchen, Steve, et al.
Publicado: (2020)

ServiceNow: building powerful workflows : automating IT service management
por: Woodruff, Tim, et al.
Publicado: (2017)

The ID NOW COVID-19, a high-speed high-performance assay
por: Farfour, Eric, et al.
Publicado: (2021)

Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021)

Fast and reliable real life data on COVID-19 triaging with ID NOW
por: Burdino, Elisa, et al.
Publicado: (2022)

Trichomonas vaginalis Detection in Female Specimens with cobas(®) TV/MG for use on the cobas(®) 6800/8800 Systems
por: Marlowe, Elizabeth M., et al.
Publicado: (2019)

Assessment of the Cobas Bio centrifugal analyser
por: Bais, Renze, et al.
Publicado: (1982)

Cobas Ampliprep/Cobas TaqMan HIV-1 v2.0 Assay: Consequences at the Cohort Level
por: Taylor, Ninon, et al.
Publicado: (2013)

Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas(®) HBV Test for Use on the Cobas(®) 4800 System
por: Ortonne, Valérie, et al.
Publicado: (2021)

Coba, Quintana Roo : análisis de dos unidades habitacionales mayas
Publicado: (1987)

Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021)

Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19
por: Krause, Eva, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_209arschhhnksbfp99h6638vmf